Jefferies Raises Price Target on BioMarin Pharma (BMRN) to $120; Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 56.63 +1.42 (2.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $55.21 | 52 Week High | $108.96 | |||
| Open | $55.40 | 52 Week Low | $62.12 | |||
| Day High | $56.91 | P/E | N/A | |||
| Day Low | $55.02 | EPS | $-1.27 | |||
| Volume | 2,396,854 | |||||
